Skip to main content
. 2013 Oct 3;145(2):331–345. doi: 10.1378/chest.13-1599

Table 1.

—Patient Characteristics

Evaluation Inconsistent With Guidelines
Variable Evaluation Consistent With Guidelines, Mediastinal Sampling Done First NSCLC Present, Mediastinal Sampling Second or Later NSCLC Present, Mediastinal Sampling Never Done Small Cell Lung Cancer Present No Evaluation Recordeda Total
All patients 3,155 (100) 4,659 (100) 5,881 (100) 1,621 (100) 615 (100) 15,931 (100)
Age, y
 66-70 1,074 (34.04) 1,527 (32.78) 1,549 (26.34) 571 (35.23) 196 (31.87) 4,917 (30.86)
 71-75 995 (31.54) 1,566 (33.61) 1,697 (28.86) 486 (29.98) 169 (27.48) 4,913 (30.84)
 76-80 761 (24.12) 1,046 (22.45) 1,521 (25.86) 360 (22.21) 143 (23.25) 3,831 (24.05)
 > 80 325 (10.3) 520 (11.16) 1,114 (18.94) 204 (12.59) 107 (17.4) 2,270 (14.25)
Sex
 Female 1,530 (48.49) 2,146 (46.06) 2,637 (44.84) 854 (52.68) 254 (41.3) 7,421 (46.58)
 Male 1,625 (51.51) 2,513 (53.94) 3,244 (55.16) 767 (47.32) 361 (58.7) 8,510 (53.42)
Race
 Non-Hispanic white 2,745 (87.01) 3,989 (85.62) 4,826 (82.06) 1,409 (86.92) 490 (79.68) 13,459 (84.48)
 Hispanic 129 (4.09) 223 (4.79) 289 (4.91) 70 (4.32) 34 (5.53) 745 (4.68)
 Non-Hispanic black 199 (6.31) 247 (5.3) 548 (9.32) 99 (6.11) 66 (10.73) 1,159 (7.28)
 Non-Hispanic other 82 (2.6) 200 (4.29) 218 (3.71) 43 (2.65) 25 (4.07) 568 (3.57)
Urban/rural
 Big metropolitan 1,763 (55.88) 2,557 (54.88) 3,092 (52.58) 799 (49.29) 320 (52.03) 8,531 (53.55)
 Metropolitan 861 (27.29) 1,266 (27.17) 1,625 (27.63) 481 (29.67) 181 (29.43) 4,414 (27.71)
 Urban 196 (6.21) 306 (6.57) 431 (7.33) 132 (8.14) 39 (6.34) 1,104 (6.93)
 Less urban 279 (8.84) 433 (9.29) 611 (10.39) 171 (10.55) 64 (10.41) 1,558 (9.78)
 Rural 56 (1.78) 97 (2.08) 122 (2.07) 38 (2.34) 11 (1.79) 324 (2.03)
Year of diagnosis
 1995 105 (3.33) 181 (3.89) 135 (2.3) 45 (2.78) 21 (3.42) 487 (3.06)
 1996 88 (2.79) 183 (3.93) 150 (2.55) 58 (3.58) 21 (3.42) 500 (3.14)
 1997 92 (2.92) 178 (3.82) 131 (2.23) 51 (3.15) 18 (2.93) 470 (2.95)
 1998 89 (2.82) 165 (3.54) 152 (2.59) 38 (2.34) 15 (2.44) 459 (2.88)
 1999 86 (2.73) 131 (2.81) 107 (1.82) 48 (2.96) 24 (3.9) 396 (2.49)
 2000 207 (6.56) 349 (7.49) 338 (5.75) 107 (6.6) 40 (6.5) 1,041 (6.53)
 2001 335 (10.62) 483 (10.37) 636 (10.81) 184 (11.35) 63 (10.24) 1,701 (10.68)
 2002 302 (9.57) 516 (11.08) 614 (10.44) 191 (11.78) 57 (9.27) 1,680 (10.55)
 2003 377 (11.95) 501 (10.75) 716 (12.18) 189 (11.66) 69 (11.22) 1,852 (11.63)
 2004 401 (12.71) 497 (10.67) 746 (12.69) 197 (12.15) 82 (13.33) 1,923 (12.07)
 2005 344 (10.9) 540 (11.59) 742 (12.62) 201 (12.4) 65 (10.57) 1,892 (11.88)
 2006 357 (11.32) 484 (10.39) 712 (12.11) 155 (9.56) 65 (10.57) 1,773 (11.13)
 2007 372 (11.79) 451 (9.68) 702 (11.94) 157 (9.69) 75 (12.2) 1,757 (11.03)
SEER/TCR region
 Atlanta and rural Georgia 68 (2.16) 164 (3.52) 218 (3.71) 44 (2.71) 14 (2.28) 508 (3.19)
 California 640 (20.29) 1,011 (21.7) 1,122 (19.08) 309 (19.06) 134 (21.79) 3,216 (20.19)
 Connecticut 239 (7.58) 392 (8.41) 327 (5.56) 108 (6.66) 53 (8.62) 1,119 (7.02)
 Detroit 353 (11.19) 387 (8.31) 477 (8.11) 115 (7.09) 42 (6.83) 1,374 (8.63)
 Hawaii 24 (0.76) 68 (1.46) 89 (1.51) 13 (0.8) 15 (2.44) 209 (1.31)
 Iowa 175 (5.55) 337 (7.23) 408 (6.94) 146 (9.01) 33 (5.37) 1,099 (6.9)
 Kentucky 209 (6.62) 353 (7.58) 475 (8.08) 171 (10.55) 37 (6.02) 1,245 (7.82)
 Louisiana 98 (3.11) 215 (4.62) 454 (7.72) 106 (6.54) 36 (5.85) 909 (5.71)
 New Jersey 395 (12.52) 462 (9.92) 576 (9.79) 144 (8.88) 64 (10.41) 1,641 (10.3)
 New Mexico 49 (1.55) 82 (1.76) 80 (1.36) 28 (1.73) < 11 (< 2)b < 250 (< 1.56)
 Seattle 146 (4.63) 198 (4.25) 217 (3.69) 45 (2.78) 38 (6.18) 644 (4.04)
 Texas 720 (22.82) 946 (20.31) 1,393 (23.69) 374 (23.07) 135 (21.95) 3,568 (22.4)
 Utah 39 (1.24) 44 (0.94) 45 (0.77) 18 (1.11) < 11 (< 1)b < 157 (< 0.99)
Charlson comorbidity index
 0 1,620 (51.35) 2,563 (55.01) 2,740 (46.59) 784 (48.37) 332 (53.98) 8,039 (50.46)
 1 959 (30.4) 1,340 (28.76) 1,800 (30.61) 498 (30.72) 148 (24.07) 4,745 (29.79)
 2+ 576 (18.26) 756 (16.23) 1,341 (22.8) 339 (20.91) 135 (21.95) 3,147 (19.75)
Poverty in patient’s census tractc
 ≤ 4.76% 886 (28.08) 1,183 (25.39) 1,316 (22.38) 369 (22.76) 145 (23.58) 3,899 (24.47)
 4.77%-9.07% 742 (23.52) 1,194 (25.63) 1,401 (23.82) 390 (24.06) 136 (22.11) 3,863 (24.25)
 9.08%-16.53% 779 (24.69) 1,071 (22.99) 1,461 (24.84) 417 (25.73) 155 (25.2) 3,883 (24.37)
 > 16.53% 619 (19.62) 997 (21.4) 1,544 (26.25) 391 (24.12) 153 (24.88) 3,704 (23.25)
 Unknown 129 (4.09) 214 (4.59) 159 (2.7) 54 (3.33) 26 (4.23) 582 (3.65)
< 12 y educationd
 ≤ 10.09% 864 (27.39) 1,239 (26.59) 1,330 (22.62) 336 (20.73) 140 (22.76) 3,909 (24.54)
 10.1%-17.18% 767 (24.31) 1,157 (24.83) 1,392 (23.67) 413 (25.48) 145 (23.58) 3,874 (24.32)
 17.19%-27.8% 765 (24.25) 1,040 (22.32) 1,471 (25.01) 417 (25.73) 162 (26.34) 3,855 (24.2)
 > 27.85% 630 (19.97) 1,009 (21.66) 1,529 (26) 401 (24.74) 142 (23.09) 3,711 (23.29)
 Unknown 129 (4.09) 214 (4.59) 159 (2.7) 54 (3.33) 26 (4.23) 582 (3.65)
Specialty of physician doing first teste
 Internal medicine 368 (11.66) 1,040 (22.32) 1,381 (23.48) 375 (23.13) 0 (0) 3,164 (19.86)
 Pulmonary 945 (29.95) 2,300 (49.37) 2,998 (50.98) 878 (54.16) 0 (0) 7,121 (44.70)
 General surgery 298 (9.45) 196 (4.21) 244 (4.15) 74 (4.57) 0 (0) 812 (5.10)
 Thoracic surgery 1,431 (45.36) 304 (6.53) 292 (4.97) 80 (4.94) 0 (0) 2,107 (13.23)
 Other 19 (0.6) 141 (3.03) 236 (4.01) 46 (2.84) 0 (0) 442 (2.77)
 Unknown 94 (2.98) 678 (14.55) 730 (12.41) 168 (10.36) 615 (100) 2,285 (14.34)
T stage
 T1b 908 (28.78) 1,105 (23.72) 869 (14.77) 322 (19.87) 133 (21.63) 3,337 (20.94)
 T2 1,342 (42.54) 2,633 (56.51) 2,993 (50.89) 728 (44.91) 243 (39.51) 7,939 (49.83)
 T3 176 (5.58) 279 (5.99) 762 (12.96) 117 (7.22) 74 (12.03) 1,408 (8.84)
 Unknown 729 (23.11) 642 (13.78) 1,257 (21.37) 454 (28.01) 165 (26.83) 3,247 (20.38)
Cancer type
NSCLC 2,680 (84.95) 4,659 (100) 5,881 (100) 0 (0) 500 (81.3) 13,720 (86.12)
 Small cell lung cancer 475 (15.06) 0 (0) 0 (0) 1,621 (100) 115 (18.7) 2,211 (13.88)

Data are presented as No. (%). NSCLC = non-small cell lung cancer; SEER = Surveillance, Epidemiology, and End Results; TCR = Texas Cancer Registry.

a

No evaluation recorded means that no Medicare payments were noted. For example, a patient who had their care delivered through the Veteran’s Administration would not show up in the Medicare dataset.

b

Strata with ≤ 10 patients were suppressed per National Cancer Institute policy and are reported as < 11 to ensure confidentiality. A total of 50 patients with T0 disease have been included in the T1 category to maintain confidentiality because there were too few patients with T0 disease to report them separately while maintaining confidentiality.

c

Poverty is the percentage of the population in the patient’s census tract living below the poverty level. Note that this does not mean that the patient’s income is below the poverty line, just that the patient is living in a census tract with that level of poverty.

d

Percentage of patients with < 12 y education is the percentage of the population in their census tract who did not graduate from high school.

e

Refers to the physician who ordered or performed the first invasive diagnostic test. For bronchoscopy and surgical procedures, this was the physician performing the procedure. For CT image-guided biopsy, this was the referring physician. Internal medicine includes family practice and all subspecialties of internal medicine other than oncology and pulmonary medicine. Surgery includes all other subspecialties of surgery other than thoracic and cardiothoracic. Thoracic surgery and cardiothoracic surgery are included under thoracic surgery.